Gennex Laboratories (BOM:531739) Total Liabilities : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Gennex Laboratories Total Liabilities?

Gennex Laboratories's Total Liabilities for the quarter that ended in Dec. 2024 was ₹0 Mil.

Gennex Laboratories's quarterly Total Liabilities increased from Jun. 2024 (₹0.00 Mil) to Sep. 2024 (₹578.05 Mil) but then declined from Sep. 2024 (₹578.05 Mil) to Dec. 2024 (₹0.00 Mil).

Gennex Laboratories's annual Total Liabilities increased from Mar. 2022 (₹242.11 Mil) to Mar. 2023 (₹458.01 Mil) and increased from Mar. 2023 (₹458.01 Mil) to Mar. 2024 (₹535.21 Mil).

Gennex Laboratories Total Liabilities Historical Data

The historical data trend for Gennex Laboratories's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gennex Laboratories Total Liabilities Chart

Gennex Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

212.72

191.92

242.11

458.01

535.21

Gennex Laboratories Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															-	535.21	-	578.05	-

Gennex Laboratories Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Gennex Laboratories's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	403.048	+	(132.164	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	535

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	2299.858	-	1764.646
	=	535

Gennex Laboratories's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	N/A

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	N/A	-	N/A
	=	N/A

Gennex Laboratories Total Liabilities Related Terms

Thank you for viewing the detailed overview of Gennex Laboratories's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Gennex Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gennex Laboratories Ltd (BOM:531739) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

Akash Ganga, Plot No. 144, 4th Floor, Srinagar Colony, Hyderabad, TG, IND, 500 073

Website

https://www.gennexlab.com

Gennex Laboratories Ltd is engaged in the manufacturing of bulk drugs, and intermediates, Biotech Products. Geographically, the group has a business presence in Bangladesh, Egypt, Germany, Guatemala, Iran, Israel and other countries. Its products include Guaifenesin, Methocarbamol, Fluconazole and Phenazopyridine, among others.

Gennex Laboratories Headlines

No Headlines